Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe site’s footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new version entry (v3.7.0) was added to the study record history, while the previous version (v3.6.6) was removed from the visible history.SummaryDifference0.1%

- Check46 days agoChange DetectedAdds Revision: v3.6.6 to the study record history and removes Revision: v3.6.5, reflecting an update to the record's versioning metadata.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the record history, and the previous 'Revision: v3.6.4' entry was removed, representing an administrative update to the history log.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history now includes a new entry for Revision: v3.6.4, and the previous Revision: v3.6.3 is removed from the list. This reflects an update to the version history rather than changes to the study content.SummaryDifference0.1%

- Check103 days agoChange DetectedA new revision entry v3.6.3 was added to the study history, superseding the previous v3.6.2 and signaling an updated version of the study record.SummaryDifference0.1%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.